Workflow
Delcath(DCTH)
icon
Search documents
Delcath Systems (DCTH) is on the Move, Here's Why the Trend Could be Sustainable
ZACKS· 2025-01-30 14:50
When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done.The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the st ...
Recent Price Trend in Delcath Systems (DCTH) is Your Friend, Here's Why
ZACKS· 2025-01-14 14:51
When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done.The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the st ...
Delcath(DCTH) - 2024 Q4 - Annual Results
2025-01-13 14:18
NASDAQ: DCTH January 2025 Corporate Presentation Deleath® Forward-Looking Statement The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This presentation contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," ...
Delcath Begins Platform Expansion With Two Phase 2 Trials
Seeking Alpha· 2024-11-20 12:50
On October 17th, Delcath Systems, Inc. (NASDAQ: DCTH ) preannounced Q3 sales results, which were $10 million in the US and $1.2 million in Europe. $10 million in quarterly US sales wasAnalyst’s Disclosure: I/we have a beneficial long position in the shares of DCTH either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company ...
Delcath Systems: Q3 Earnings Reveal HEPZATO KIT And CHEMOSAT Growth
Seeking Alpha· 2024-11-18 12:09
Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial.It has been over three years since my last Delcath Systems (NASDAQ: DCTH ) article , where I highlighted the company’s efforts in moving closer to submitting their NDA for their drug/device kit of melphalanHe is the leader of the investing group Compound ...
Delcath(DCTH) - 2024 Q3 - Earnings Call Transcript
2024-11-08 17:30
Delcath Systems Inc (NASDAQ:DCTH) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants David Hoffman - General Counsel, Corporate Secretary & Chief Compliance Officer Gerard Michel - CEO Sandra Pennell - SVP, Finance Kevin Muir - General Manager, Interventional Oncology Vojislav Vukovic - Chief Medical Officer Conference Call Participants Sudan Loganathan - Stephens Swayampakula Ramakanth - H.C. Wainwright John Newman - Canaccord Genuity Corp Yale Jen - Laidlaw & Company Chase K ...
Delcath Systems, Inc. (DCTH) Reports Q3 Loss
ZACKS· 2024-11-08 15:11
Delcath Systems, Inc. (DCTH) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.61 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 76.92%. A quarter ago, it was expected that this company would post a loss of $0.34 per share when it actually produced a loss of $0.48, delivering a surprise of -41.18%.Over the last four quarters, the company has s ...
Delcath(DCTH) - 2024 Q3 - Quarterly Report
2024-11-08 14:46
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _____________________ FORM 10-Q ______________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 Or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-16133 ______________________ DELCATH SYSTEMS, I ...
Delcath(DCTH) - 2024 Q3 - Quarterly Results
2024-11-08 13:13
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Title of each classTrading symbol(s)Name of each exchange on which registered Common Stock, $.01 par value DCTH The Nasdaq Capital Market FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2024 DELCATH SYSTEMS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-16133 06-1245881 (State or other jurisdiction of inc ...
Wall Street Analysts Believe Delcath Systems (DCTH) Could Rally 96.84%: Here's is How to Trade
ZACKS· 2024-11-05 15:56
Delcath Systems, Inc. (DCTH) closed the last trading session at $10.77, gaining 26.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $21.20 indicates a 96.8% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $2.59. While the lowest estimate of $18 indicates a 67.1% increase from the current price level, the most optimistic anal ...